“…HPV inhibitors include volatile anesthetics (halothane and enflurane >isoflurane, sevoflurane and desflurane)systemic vasodilators (nitroglycerin, sodium nitroprusside, dobutamine, calcium channel blockers, and β2 agonists), pulmonary artery pressure extremes, hypocapnia, mixed venous oxygen tension extremes and pulmonary infection [9,10]. We employed less than one MAC of sevoflurane supplemented by a BIS-guided propofol infusion during OLV to prevent awareness since propofol does not inhibit HPV [11]. Factors decreasing blood flow to ventilated lung (high peak or mean airway pressures, high PEEP), hyperventilation, low fraction of inspired oxygen (FiO 2 ), vasoconstrictors (dopamine, epinephrine, and phenylephrine) causing greater vasoconstriction of normoxic vessels than hypoxic vessels were factors which we avoided.…”